Clinical Trial Update: Lorazepam-Induced Toxicity in the Aged [Phase 4]

View source ↗

Summary

Phase 4 clinical trial update highlighting lorazepam-associated toxicity in older adults, raising safety considerations for patients with anxiety disorders.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Anxiety Disorders
• Generalized Anxiety Disorder

Drugs mentioned

• Lorazepam (Lorazepam)

Snippet

Sponsor: Nathan Kline Institute for Psychiatric Research | Conditions: Anxiety Disorders, Generalized Anxiety Disorder | Phase 4 | Status: COMPLETED